ArticleCancers2021

Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes.

Charline Lafayolle de la Bruyère et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.